Merck says it's experimental COVID-19 pill reduced hospitali

The study of the experimental drug found 7.3% of the treatment group were either hospitalized or died at the end of 30 days, compared with 14.1% of those getting a dummy pill

Related Keywords

United States , Kenilworth , Warwickshire , United Kingdom , America , Mel Evans , Ridgeback Biotherapeutics , Anthony Fauci , Pfizer , Science Department , Drug Administration , Merck Co , Nj Merck Co , Department Of Science Education , Howard Hughes Medical Institute , Latin America , Associated Press Health , Dailymail , Health , Coronavirus ,